Ignite Creation Date:
2026-03-26 @ 3:14 PM
Ignite Modification Date:
2026-04-14 @ 3:44 AM
Study NCT ID:
NCT07363395
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-01-23
First Post:
2026-01-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety, Tolerability, and Pharmacokinetics of ASCT-83 in Healthy Adults
Sponsor:
Alcamena Stem Cell Therapeutics
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Neuropathic Pain | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Neuropathic Pain | View |
| None | Nerve Regeneration | View |
| None | Analgesic | View |
| None | CTDSP1 Inhibitor | View |
| None | REST (RE1-silencing transcription factor) | View |
| None | Macrocyclic Peptide | View |
| None | Target Engagement | View |
| None | First-in-Human (FIH) | View |
| None | SAD/MAD | View |
| None | Healthy Volunteers | View |
| None | Pharmacokinetics (PK) | View |
| None | Diabetic Peripheral Neuropathy (DPN) | View |
| None | Peripheral Nerve Injury (PNI) | View |